Amanda Rose Saccomanno - May 20, 2022 Form 3 Insider Report for Limitless X Holdings Inc. (VYBE)

Role
Director
Signature
/s/ Amanda Rose Saccomanno
Stock symbol
VYBE
Transactions as of
May 20, 2022
Transactions value $
$0
Form type
3
Date filed
7/29/2022, 03:56 PM
Next filing
Oct 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VYBE Common Stock, par value $0.001 per share 2.91M May 20, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 20, 2022, pursuant to a Share Exchange Agreement dated May 11, 2022 (the "Agreement") by and between Limitless X Holdings Inc. ("Limitless") and Bio Lab Naturals Inc. (the "Issuer"), the reporting person exchanged 1,500,000 shares of Limitless common stock ("Company Shares") for 2,910,000 shares of the common stock of the Issuer (the "Exchange Shares") with the exchange ratio being 1.94 Exchange Shares for each Company Share.